Professional Documents
Culture Documents
Title Page
Introduction
What is Bio-preservation?
Biological methods for food preservation
Natural antimicrobials for food bio
preservation
What is Bacteriocins?
Common bacteriocins and their possible
uses in food industry.
What is Probiotic?
Characteristics of probiotics
Conclusion
The foods of animal origin are highly perishable due to high nutritional content, moisture
and neutral pH. These foods require proper preservation to maintain quality and safety.
Failing which leads to human illnesses and disease outbreaks. These food borne
illnesses are serious and costly public health concern worldwide. So to maintain the
quality and safety of foods various measures are generally adopted in food industry i.e.
good manufacturing practices, good hygienic practices tec. But preservation of food by
a suitable means is the key of food quality and safety. There are number of preservation
techniques started from low temperature preservation like refrigeration, freezing etc.
and thermal preservation techniques like pasteurization, sterilization and preservation
using certain chemicals. Now a day modern preservation techniques like bio-
preservation, irradiation and hurdle technologies are also common. In traditional
preservation techniques food alters their status and loss some nutrients. So the modern
techniques are more suitable to achieve the safety and quality of foods. It is also
relevant in today world due to globalization of food market, introduction of novel foods,
innovations of new technologies, demand of minimally processed products with ready–
to-eat quality and longer shelf life. Among all the preservation techniques adopted now
bio-preservation is more reliable from ‘farm to fork’ concept. It is capable to enhance
shelf life with great quality, hygienic status with minimal nutritional and organoleptic
losses.
Bio-preservation
The use of micro-biota and/or antimicrobials in shelf life enhancement of foods is a new
branch of science. The fermentation is a typical example of this process in which
microbes are grown naturally or by addition. Fermentation process produces numbers
of beneficial products with the bacteria which helps in reduction of food spoilage and
renders the food free from pathogenic microorganisms and metabolites. This organism
used for the purpose is LAB and their compounds like organic acids which are capable
to exert antimicrobial properties as well as imparts unique flavor and texture to the food
products. In industrialized world about 60 percent food items are subjected to
fermentation to assure homogeneity, quality, and safety of products. They prefer to use
native micro-biota under controlled environment to get typical texture and flavor for a
specific product. The major use of micro-biota in food industry is in dairy industry but
they can also be exploited in meat and vegetable products. Bio-preservatives eligible for
use in food must fall under the category of generally recognized as safe with no
pathogenic and toxic effect on food. Biological agents used in food may be categorized
as starter cultures and protective cultures. Starter cultures are generally used group of
microorganisms which are used to initiate the fermentation and helps in production of
certain compounds responsible for typical texture and flavoring compounds in
fermented products. The protective culture is mainly used to control the antimicrobial
activity and reduces the survival and growth of pathogenic micro-organisms in foods.
However, combination of both starter and protective culture is generally preferred for
use in food industry.
Natural antimicrobials for food bio-preservation
Heterofermentative
LAB produces Creation of an anaerobic environment and
CO2 CO2 as a byproduct antagonistic effects specifically against aerobic
of sugar bacteria and produce carbonic acid.
fermentation.
bacterial cell Hydrogen peroxide and action of of proteins and increase of membrane
Low molecular-
weight antimicrobial
Antimicrobial activity against bacteria as well
compound produced
Reuterin as yeasts and molds by inhibiting DNA
by Lactobacillus
synthesis.
reuteri and some
other LAB.
Antimicrobial system
Lactoperoxidase that originated from Effective against gram-negative bacteria.
milk.
Produced by
Ovotransferrin hydrolysis of natural Inhibits bacterial growth due to iron deprivation.
proteins.
Present in myeloid
Antimicrobial activity against several food
cells and mucosal
borne bacteria such as L.
Pleurocidin tissues of many
monocytogenes and E. coliO157:H7, and
vertebrates and
pathogenic fungi.
Invertebrates.
Bacteriocins
Probiotic
Probiotics are live microbes that can be formulated into many different types of
products, including foods, drugs, and dietary supplements. Probiotic is a relatively new
word that is used to name the bacteria associated with the beneficial effects for the
humans and animals. The term probiotic means ‘‘for life’’ and it was defined by an
Expert Committee as ‘‘live microorganisms which upon ingestion in certain numbers
exert health benefits beyond inherent general nutrition’’.
Characteristics of probiotics
Characteristics of probiotics will determine their ability to survive the upper digestive
tract and to colonize in the intestinal lumen and colon for an undefined time period.
Probiotics are safe for human consumption and no reports have found on any
harmfulness or production of any specific toxins by these strains. In addition, some
probiotics could produce antimicrobial substances like bacteriocins. Therefore, the
potential health benefit will depend on the characteristic profile of the probiotics. Some
probiotic strains can reduce intestinal transit time, improve the quality of migrating motor
complexes [9], and temporarily increase the rate of mitosis in enterocytes.
Human health
Several studies have documented probiotic effects on a variety of gastrointestinal and
extraintestinal disorders, including prevention and alleviation symptoms of traveler’s
diarrhea and antibiotic associated diarrhea, inflammatory bowel disease, lactose
intolerance, protection against intestinal infections, and irritable bowel syndrome. Some
probiotics have also been investigated in relation to reducing prevalence of atopic
eczema later in life, vaginal infections, and immune enhancement, contributing to the
inactivation of pathogens in the gut, rheumatoid arthritis, improving the immune
response of in healthy elderly people and liver cirrhosis. Some probiotic preparations
have been used to prevent diarrhea caused by antibiotics, or as part of the treatment for
antibiotic-related dysbiosis. Although there is some clinical evidence for the role of
probiotics in lowering cholesterol but the results are conflicting. Probiotics have a
promising inhibitory effect on oral pathogens especially in childhood but this may not
necessarily lead to improved oral health. Antigenotoxicity, antimutagenicity and
anticarcinogenicity are important potential functional properties of probiotics, which have
been reported recently. Observational data suggest that consumption of fermented dairy
products is associated with a lower prevalence of colon cancer, which is suggested that
probiotics are capable of decreasing the risk of cancer by inhibition of carcinogens and
pro-carcinogens, inhibition of bacteria capable of converting pro-carcinogens to
carcinogens.
Animal health
Probiotics which are traditional idea in the human food have been extended to animals
by developing fortified feed with intestinal micro biota to benefit the animals. The micro
flora in the gastrointestinal tracts of animals plays a key role in normal digestive
processes and in maintaining the animal’s health. Probiotics can beneficially improve
the intestinal microbial balance in host animal. Commercial probiotics for animal use are
claimed to improve animal performance by increasing daily gain and feed efficiency in
feedlot cattle, enhance milk production in dairy cows, and improve health and
performance of young calves and in improving growth performance of chickens.
Probiotics can attach the mucosal wall, adjust to immune responses, and compete the
pathogenic bacteria for attachment to mucus. Probiotics provide the animal with
additional source of nutrients and digestive enzymes. They can stimulate synthesis
vitamins of the B-group and enhancement of growth of nonpathogenic facultative
anaerobic and gram positive bacteria by producing inhibitory compounds like volatile
fatty acids and hydrogen peroxide that inhibit the growth of harmful bacteria enhancing
the host’s resistance to enteric pathogens . Finally, probiotics can inhibit pathogens by
competition for a colonization sites or nutritional sources and production of toxic
compounds, or stimulation of the immune system.
Plant health
The more beneficial the bacteria and fungi are, the more “fertile” the soil is. These
microorganisms break down organic matter in the soil into small, usable parts that
plants can uptake through their roots. The healthier the soil, the lower need for synthetic
herb or pesticides and fertilizers. The concept that certain microorganisms ‘probiotics’
may confer direct benefits to the plant acting as bio-control agents for plants. The plant
probiotic bacteria have been isolated and commercially developed for use in the
biological control of plant diseases or bio-fertilization. These microorganisms have
fulfilled important functions for plant as they antagonize various plant pathogens, induce
immunity, or promote growth. The interaction between bacteria and fungi with their host
plants has shown their ability to promote plant growth and to suppress plant pathogens
in several studies.
The presence of probiotics in commercial food products has been claimed for certain
health benefits. This has led to industries focusing on different applications of probiotics
in food products and creating a new generation of ‘probiotic health’ foods.
Probiotics can be found in a wide variety of commercial dairy products including sour
and fresh milk, yogurt, cheese, etc.
Among probiotics carrier food products, dairy drinks were the first commercialized
products that are still consumed in larger quantities than other probiotic beverages.
Among the probiotic bacteria used in the manufacture of dairy beverages, L.
rhamnosus GG is the most widely used.
Yogurt- Yogurt is one of the original sources of probiotics and continues to remain a
popular probiotic product today. Yogurt is known for its nutritional value and health
benefits. Yogurt is produced using a culture of L. delbrueckii subsp. bulgaricus and
Streptococcus salivarius subsp. thermophilus bacteria.
Cheese- Yogurt and milk are the most common vehicles of probiotics among dairy
products. However, alternative carriers such as cheese seem to be well suited.
Other dairy based products- Other dairy products including quark, chocolate
mousse, frozen fermented dairy desserts, sour cream, and ice cream can be good
vehicles of probiotics.
Probiotics application challenges
Conclusion
1. Atterbury RJ, Dillon E, Swift C, Connerton PL, Frost JA, Dodd CE, Rees CE,
Connerton IF. Correlation of Campylobacter bacteriophage with reduced
presence of hosts in broiler chicken ceca. Appl. Environ. Microbial. 2005;
71:4885–4887.
2. Azeredo J, Sutherland I. The use of phages for the removal of infectious
biofilms. Curr. Opin. Biotechnology. 2008; 9:261–266.
3. Brede DA, Lothe S, Salehian Z, Faye T, Nes IF. Identification of the propionicin F
bacteriocin immunity gene (pcfI) and development of a food-grade cloning
system for Propionibacterium freudenreichii. Appl. Environ. Microbial. 2007;
73:7542–7547.
4. Breukink E, Wiedemann I, Van Kraaij C, Kuipers OP, Sahl HG, De Kruijff B. Use
of the cell wall precursor lipid II by a pore-forming peptide antibiotic. Sci. 1999;
286:2361–2364.
5. Brüssow H, Kutter E. Phage ecology. In: Kutter E, Sulakvelidze A,
editors. Bacteriophages: biology and applications. Florida: Boca Raton CRC
Press; 2005. pp. 129–163.
6. Carlton RM, Noordman WH, Biswas B, De Meester ED, Loessner MJ.
Bacteriophage for control of Listeria monocytogenes in foods: Genome
sequence, bioinformatic analyses, oral toxicity study, and application. Regul.
Toxicol. Pharmacol. 2005; 43:301–312.
7. Chopra L, Singh G, Jena KK, Sahoo DK. Sonorensin: a new bacteriocin with
potential of an anti-biofilm agent and a food biopreservative. Sci. Rep. 2015;
5:13412. Doi: 10.1038/srep13412.
8. Devlieghere F, Vermeiren L, Debevere J. New preservation technologies:
Possibilities and limitations. Int. Dairy J. 2004; 14:273–285.
9. Donovan DM, Lardeo M, Foster-Frey J. Lysis of staphylococcal mastitis
pathogens by bacteriophage phi11 endolysin. FEMS Microbiol. Lett. 2006;
265:133–489.
10. Elsabee MZ, Abdou ES. Chitosan based edible films and coatings: a
review. Mater. Sci. Eng. C. Mater. Biol. Appl. 2013; 33:1819–1841.
11. Ackermann HW. 5500 Phages examined in the electron microscope. Arch.
Virol. 2007; 152:227–243.
12. Fiorentin L, Vieira ND, Barioni W., Jr Oral treatment with bacteriophages reduces
the concentration of Salmonella enteritidis PT4 in caecal contents of
broilers. Avian Pathol. 2005; 34:258–263.
13. Ganguly S. Basic principles for effective food preservation: a review. Int. J. Pure
App. Biosci. 2013; 1(6):84–85.
14. García-Bayona L, Guo SM, Laub TM. Contact-dependent killing by Caulobacter
crescentus via cell surface-associated, glycine zipper proteins. ELife. 2017;
6:e24869. doi:10.7554/eLife.24869.
15. Gyawali R, Ibrahim SA. Natural products as antimicrobial agents. Food
Control. 2014; 46:412–429.
16. Hanlon GW. Bacteriophages: an appraisal of their role in the treatment of
bacterial infections. Int. J. Antimicrob. Agents. 2007; 30:118–128.
17. Kim KP, Klumpp J, Loessner MJ. Enterobacter sakazakii bacteriophages can
prevent bacterial growth in reconstituted infant formula. Int. J. Food
Microbiol. 2007; 115:195–203.
18. Lönnerdal B. Biological effects of novel bovine milk fractions. Nestle Nutr
Workshop Ser Paediatr Program. 2011; 67:41–54.
19. Lucera A, Costa C, Conte A, Del Nobile MA. Food applications of natural
antimicrobial compounds. Front Microbiol. 2012;
3:287. doi:10.3389/fmicb.2012.00287.
20. Martínez B, Böttiger T, Schneider T, Rodríguez A, Sahl HG, Wiedemann I.
Specific interaction of the unmodified bacteriocin Lactococcin 972 with the 562
cell wall precursor lipid II. Appl. Environ. Microbiol. 2008; 74:4666–4670.
21. Modi R, Hirvi Y, Hill A, Griffiths MW. Effect of phage on survival of Salmonella
enteritidis during manufacture and storage of Cheddar cheese made from raw
and pasteurized milk. J. Food Protect. 2001; 64:927–933.
22. Mokoena MP. Lactic Acid Bacteria and Their Bacteriocins: Classification,
Biosynthesis and Applications against Uropathogens: A Mini-
Review. Molecules. 2017;22:1255.doi:10.3390/molecules22081255.
23. Raya RR, Varey P, Oot RA, Dyen MR, Callaway TR, Edrington TS, Kutter EM,
Brabban AD. Isolation and characterization of a new T-even bacteriophage,
CEV1, and determination of its potential to reduce Escherichia coli O157: H7
levels in sheep. Appl. Environ. Microbiol. 2006; 72:6405–6410.
24. Rilla N, Martínez B, Delgado T, Rodríguez A. Inhibition of Clostridium
tyrobutyricum in Vidiago cheese by Lactococcus lactis ssp lactis IPLA 729, a
nisin Z producer. Int. J. Food Microbiol. 2003; 85:23–33.
25. Rilla N, Martínez B, Rodríguez A. Inhibition of a methicillin-
resistant Staphylococcus aureus strain in Afuega'l Pitu cheese by the nisin Z-
producing strain Lactococcus lactis subsp lactis IPLA 729. J. Food Protect. 2004;
67:928–933.
26. Ryan MP, Ross RP, Hill C. Strategy for manipulation of cheese flora using
combinations of lacticin 3147-producing and -resistant cultures. Appl. Environ.
Microbiol. 2001; 67:2699–2704.
27. Salem AM. Bio-preservation challenge for shelf-life and safety improvement of
minced beef. Global J. Biotech. Biochem. 2012; 7(2):50–60.
28. Sulakvelidze A, Kutter E. Bacteriophage therapy in humans. In: Kutter E,
Sulakvelidze A, editors. Bacteriophages: Biology and Applications. Florida: Boca
Raton, CRC Press; 2005. pp. 381–436.
29. Turner MS, Waldherr F, Loessner MJ, Giffard PM. Antimicrobial activity of
lysostaphin and a Listeria monocytogenes bacteriophage endolysin produced
and secreted by lactic acid bacteria. Syst. Appl. Microbiol. 2007; 30:58–67.
30. Wiedemann I, Breukink E, Van Kraaij C, Kuipers OP, Bierbaum G, De Kruijff B,
Sahl HG. Specific binding of nisin to the peptidoglycan precursor 616 lipid II
combines pore formation and inhibition of cell wall biosynthesis for potent 617
antibiotic activities. J. Bio. Chem. 2001; 276:1772–1779.
31. Xie L, van der Donk WA. Post-translational modifications during lantibiotic
biosynthesis. Curr. Opin. Chem. Biol. 2004;8(5):498–507.
32. Yoong P, Schuch R, Nelson D, Fischetti VA. Identification of a broadly active
phage lytic enzyme with lethal activity against antibiotic resistant Enterococcus
faecalis and Enterococcus faecium. J. Bacteriol. 2004; 186:4808–4812.
33. Young RY, Wang IN, Roof WD. Phages will out: strategies of host cell
lysis. Trends Microbiol. 2000; 8:120–128.